American Vanguard (AVD) investor relations material

Executive summary

• Net sales rose 7% year-over-year to $124 million in Q1 2026, led by strong U.S. crop and specialty product growth, while international sales declined 7% due to timing issues in Brazil and India.

• Gross margin expanded by 500 basis points to 31%, reflecting favorable product mix and operational efficiency.

• Adjusted EBITDA surged 245% to $10.3 million, driven by higher-margin product sales and improved cost structure.

• Net loss narrowed to $4.1 million ($0.14 per share) from $8.5 million ($0.30 per share) in Q1 2025.

• Strategic actions included manufacturing optimization, leadership changes, and a new capital structure to support long-term growth.

Financial highlights

• Net sales increased to $124 million from $116 million in Q1 2025, a 7% rise year-over-year.

• Adjusted EBITDA reached $10.3 million, up from $3 million, reflecting a 245% increase.

• Gross profit rose 27% to $38.4 million, with gross margin improving to 31% from 26% year-over-year.

• Cash at quarter-end was $71 million, up from $12 million a year ago, mainly due to debt restructuring.

• Net debt increased to $196 million, up from $154 million, primarily due to new term loans and lower customer prepayments.

Outlook and guidance

• Full-year 2026 guidance reaffirmed: sales of $530–$550 million and adjusted EBITDA of $44–$48 million.

• Targeting over $600 million in annualized revenue by 2028, with a long-term goal of double-digit EBITDA margins and a net leverage ratio of 3.0x.

• Plans to launch 50 new products over five years, aiming for $100 million in annualized revenue by 2030.

• Focused on reducing net debt, improving free cash flow, and strengthening the balance sheet over the next two years.

• Management expects all remaining customer prepayments to be recognized as revenue in fiscal 2026.